CLINICAL_TRIALS
trial_result
· 2026-03-25
Clinical Trial Update: Investigation of the NMDA Antagonist Ketamine as a Treatment for Tinnitus [Phase 2]
Summary
Phase 2 trial evaluating the NMDA receptor antagonist ketamine for tinnitus has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: New York State Psychiatric Institute | Conditions: Tinnitus | Phase 2 | Status: COMPLETED | Results posted: 2026-03-25